Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01632774
Other study ID # TAR
Secondary ID
Status Completed
Phase N/A
First received June 28, 2012
Last updated July 2, 2012
Start date January 1990
Est. completion date December 2003

Study information

Verified date June 2012
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority Switzerland: Laws and standards
Study type Observational

Clinical Trial Summary

Aortic injuries after blunt thoracic trauma are compared to the great incidence of accidents relatively rare, but potentially serious leading to death at scene in most of the cases. The study was undertaken to delineate mortality and its risk factors on three different levels (pre-hospital, in-hospital and overall). Between 1990 and 2003, all consecutive patients and victims with traumatic aortic rupture were retrospectively analyzed by reviewing hospital and autopsy records.


Description:

During the study period of 14 years (January 1990 to December 2003), all consecutive cases with traumatic rupture of the thoracic aorta being reported in the greater area of Zurich with about one million inhabitants were included in the present study. Related to the final outcome, patient data were drawn either from medical reports from the University Hospital of Zurich, which is a tertiary care teaching hospital and level I trauma center for the eastern part of Switzerland, or from autopsy reports from the Institute of Forensic Medicine of the University of Zurich, respectively. The latter group includes all patients, who died on the scene, in a assigning primary care hospital or on the way to the University Hospital of Zurich. In Switzerland, the criteria used for performing a full autopsy after a blunt traumatic death include all cases in which the events leading to the death are unclear or in which the cause of death is the result of suicide or extrinsic harm. Both, deaths at the scene and in-hospital deaths were included in the study.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date December 2003
Est. primary completion date December 2003
Accepts healthy volunteers No
Gender Both
Age group 16 Years and older
Eligibility Inclusion criteria:

- During the study period of 14 years (January 1990 to December 2003), all consecutive cases with traumatic rupture of the thoracic aorta being reported in the greater area of Zurich with about one million inhabitants were included in the present study

Exclusion criteria:

- Non-traumatic aortic rupture

- Non-traumatic aortic dissection

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
Switzerland University Hospital Zurich, Division of Internal Medicine Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

See also
  Status Clinical Trial Phase
Completed NCT03172390 - In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance N/A
Active, not recruiting NCT03414866 - Thoraflex Hybrid Post-Market Study
Recruiting NCT04937868 - Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
Recruiting NCT05065996 - Prediction of Aortic Dilatation and Rupture
Completed NCT02724072 - Thoraflex™ Hybrid IDE Study N/A
Not yet recruiting NCT04307888 - Spanish Percutaneous Aortic INtervention REGISTRY (SPAIN REGISTRY)